Stroke and Mesenchymal Stem Cells

A stroke is a sudden interruption in the blood supply to the brain. This interruption can be caused by the blockage of an artery or the leaking of a blood vessel. When this happens, the brain tissue is deprived of oxygen and nutrients, and it begins to die. Mesenchymal stem cells (MSCs) are a type of adult stem cell that can be found in many tissues, including the bone marrow, adipose tissue, and even the umbilical cord. MSCs have the ability to differentiate into a variety of cell types, including osteoblasts, chondrocytes, and adipocytes. MSCs have shown promise in the treatment of strokes. In animal models, MSCs have been shown to improve stroke outcomes by reducing brain damage and promoting neurological recovery. In one study, MSCs were injected into the brains of rats 24 hours after they had a stroke. The rats that received the MSCs had significantly less brain damage and better neurological recovery than the rats that did not receive the MSCs. MSCs may also be useful in the treatment of other neurological disorders, such as Alzheimer's disease, Parkinson's disease, and traumatic brain injury.

 "Mesenchymal Stem Cell-Based Therapy for Stroke - NCBI." 9 Feb. 2021, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899984/. Accessed 20 Oct. 2022.

 "Mesenchymal Stem Cells for Ischemic Stroke - Neurology.org." 16 Feb. 2021, https://n.neurology.org/content/96/7/301. Accessed 20 Oct. 2022.

 "Efficacy of Intravenous Mesenchymal Stem Cells for Motor Recovery ...." 29 Sep. 2021, https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.034505. Accessed 20 Oct. 2022.

The information below is the recommended stem cell therapy protocol for this condition 

Route of AdministrationDoseTime (Days)Total Cells
IV50,000,0003150,000,000
Intrathecal50,000,000150,000,000
Vitamins (Myers cocktail/NAD)1N/A
Total200,000,000